Correlation Between Serum Amisulpride Concentration, Therapeutic Efficacy, and Glycolipid Metabolism in the Treatment of Adult Female Schizophrenia
Actas Españolas de Psiquiatría · 2025
DOI: 10.62641/aep.v53i4.1806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Actas Españolas de Psiquiatría, 2025. Verfasst von Yajun Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory, The Third People's Hospital of Yongkang, 321300 Yongkang, Zhejiang, China. Hauptthemen laut MEDLINE: Amisulpride, Schizophrenia, Antipsychotic Agents, Glycolipids. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Amisulpride is a novel atypical antipsychotic (AAP) with slower absorption, metabolism, and excretion in females, potentially leading to elevated plasma concentrations. This study aimed to explore the correlation between serum amisulpride levels and therapeutic efficacy, glycolipid metabolism and side effects in adult female patients with schizophrenia (SCH).
Methods
A retrospective study was conducted involving 122 adult female SCH patients admitted to the Third People's Hospital of Yongkang between January 2020 and January 2022. Fasting venous blood samples were collected at baseline and 1, 2, 4 and 8 weeks post-treatment with amisulpride. Key parameters measured included serum amisulpride concentration, Brief Psychiatric Rating Scale (BPRS) scores, fasting blood glucose, total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and side effect scores.
Results
Serum amisulpride levels significantly increased at 2, 4, and 8 weeks compared to the first week (p < 0.05), while BPRS scores significantly decreased at all time points compared to those before treatment (p < 0.05). A strong negative correlation was observed between amisulpride concentration and BPRS scores (r = –0.948, p < 0.001). Significant alterations in fasting blood glucose, TC, TG, HDL, and LDL levels were observed post-treatment (p < 0.05). Serum amisulpride concentration negatively correlated with fasting blood glucose, TC, and LDL (r = –0.622, –0.160, –0.796, respectively, p < 0.001) and positively correlated with TG (r = 0.447, p < 0.001). Side effects scores increased significantly after 2, 4, and 8 weeks compared to the first week (p < 0.05), with amisulpride concentration positively correlating with side effects scores (r = 0.739, p < 0.001).
Conclusion
Serum amisulpride levels in female SCH patients are closely correlated with therapeutic efficacy, glycolipid metabolism and incidence of side effects, respectively. Monitoring serum concentrations may provide valuable insights for guiding personalized medication management and optimize treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory, The Third People's Hospital of Yongkang, 321300 Yongkang, Zhejiang, China.
- Ward 4, The Third People's Hospital of Yongkang, 321300 Yongkang, Zhejiang, China.
- Department of Laboratory, Yongkang Hospital, 321399 Yongkang, Zhejiang, China.
Zitieren
APA
Lin, Y., Xu, W., Yu, L., & Chen, Y. (2025). Correlation Between Serum Amisulpride Concentration, Therapeutic Efficacy, and Glycolipid Metabolism in the Treatment of Adult Female Schizophrenia. Actas Españolas de Psiquiatría. https://doi.org/10.62641/aep.v53i4.1806
Vancouver
Lin Y, Xu W, Yu L, Chen Y. Correlation Between Serum Amisulpride Concentration, Therapeutic Efficacy, and Glycolipid Metabolism in the Treatment of Adult Female Schizophrenia. Actas Españolas de Psiquiatría. 2025. doi:10.62641/aep.v53i4.1806
BibTeX
@article{Lin2025,
author = {Lin, Yajun and Xu, Weidong and Yu, Lulu and Chen, Yingying},
title = {Correlation Between Serum Amisulpride Concentration, Therapeutic Efficacy, and Glycolipid Metabolism in the Treatment of Adult Female Schizophrenia},
journal = {Actas Españolas de Psiquiatría},
year = {2025},
doi = {10.62641/aep.v53i4.1806}
}
EUVIMED